UB Paderborn / Katalog / Suche / in CDI

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)

Cochrane database of systematic reviews, 2018-07, Vol.7 (7), p.CD012556-CD012556

2018

Volltextzugriff (PDF)

Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

Cochrane database of systematic reviews, 2017-02, Vol.2017 (2)

2017

Volltextzugriff (PDF)

Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective

European journal of haematology, 2017-02, Vol.98 (2), p.169-176

2017

Volltextzugriff (PDF)

Outcome of Patients Experiencing Progression or Relapse After Primary Treatment With Two Cycles of Chemotherapy and Radiotherapy for Early-Stage Favorable Hodgkin's Lymphoma

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2000-2005

2007

Volltextzugriff (PDF)

Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study Group

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1522-1529

2005

Volltextzugriff (PDF)

Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach

Supportive care in cancer, 2011-07, Vol.19 (7), p.1037-1043

2011

Volltextzugriff (PDF)

Angewandtes Case Management: Ein Praxisleitfaden für das Krankenhaus

1st ed., 2015

Volltextzugriff (PDF)

Recommending early integration of palliative care — does it work?

Supportive care in cancer, 2012-03, Vol.20 (3), p.507-513

2012

Volltextzugriff (PDF)

Specifying WHO recommendation: moving toward disease-specific guidelines

Journal of palliative medicine, 2010-10, Vol.13 (10), p.1273

2010

Volltextzugriff (PDF)

New treatments for Hodgkin's disease

Current treatment options in oncology, 2002-07, Vol.3 (4), p.283-290

2002

Volltextzugriff (PDF)

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

Annals of hematology, 2007-02, Vol.86 (2), p.107-115

2007

Volltextzugriff (PDF)

Thalidomide for systemic capillary leak syndrome

The American journal of medicine, 2003-09, Vol.115 (4), p.332-334

2003

Volltextzugriff (PDF)

Angewandtes Case Management

2015

Volltextzugriff (PDF)

Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement

Leukemia & lymphoma, 2003-09, Vol.44 (9), p.1619-1621

2003

Volltextzugriff (PDF)

Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma

Annals of hematology, 2005-08, Vol.84 (8), p.517-525

2005

Volltextzugriff (PDF)

Economic burden of clinical trials in lung cancer in a German comprehensive cancer center

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18278-e18278

2016

Volltextzugriff (PDF)

The network genomic medicine cost reimbursement model for implementation of comprehensive lung cancer genotyping in clinical routine

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12556-e12556

2015

Volltextzugriff (PDF)

Survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: Results of the German Network Genomic Medicine

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9085-9085

2016

Volltextzugriff (PDF)

Regular Aspirin Use and Risk of Non-Hodgkin Lymphoma: A Prospective Analysis in the Nurses’ Health Study

BLOOD, 2014-12, Vol.124 (21), p.2990-2990

2014

Volltextzugriff (PDF)

Outcome and Risk Factors of Hodgkin Lymphoma Patients with Relapse or Progression After Autologous Stem Cell Transplant: A Report From the German Hodgkin Study Group (GHSG)

Blood, 2012-11, Vol.120 (21), p.2633-2633

2012

Volltextzugriff (PDF)

Cancer Care: New Value Chains Challenge German Hospital Structures—A Comprehensive Cancer Center Perspective

Boundaryless Hospital, p.21-40

Volltextzugriff (PDF)

Conjunctival melanoma : Standard operating procedures in diagnosis, treatment and follow-up care

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2018-06, Vol.115 (6), p.489-498

2018

Volltextzugriff (PDF)

Rituximab Added to an Intensified Salvage Chemotherapy Program Followed by Autologous Stem Cell Transplantation Improve in Relapsed and Refractory Aggressive Non-Hodgkin-Lymphoma

Blood, 2005-11, Vol.106 (11), p.1150-1150

2005

Volltextzugriff (PDF)

Comparison of the Sequential High-Dose Chemotherapy Followed by Autologous Stem Cell Support with and without Rituximab in Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Blood, 2004-11, Vol.104 (11), p.919-919

2004

Volltextzugriff (PDF)

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy: results of a randomized trial

Annals of hematology, 2003-08, Vol.82 (8), p.469-475

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)

Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective

Outcome of Patients Experiencing Progression or Relapse After Primary Treatment With Two Cycles of Chemotherapy and Radiotherapy for Early-Stage Favorable Hodgkin's Lymphoma

Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study Group

Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach

Angewandtes Case Management: Ein Praxisleitfaden für das Krankenhaus

Recommending early integration of palliative care — does it work?

Specifying WHO recommendation: moving toward disease-specific guidelines

New treatments for Hodgkin's disease

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

Thalidomide for systemic capillary leak syndrome

Angewandtes Case Management

Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement

Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma

Economic burden of clinical trials in lung cancer in a German comprehensive cancer center

The network genomic medicine cost reimbursement model for implementation of comprehensive lung cancer genotyping in clinical routine

Survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: Results of the German Network Genomic Medicine

Regular Aspirin Use and Risk of Non-Hodgkin Lymphoma: A Prospective Analysis in the Nurses’ Health Study

Outcome and Risk Factors of Hodgkin Lymphoma Patients with Relapse or Progression After Autologous Stem Cell Transplant: A Report From the German Hodgkin Study Group (GHSG)

Cancer Care: New Value Chains Challenge German Hospital Structures—A Comprehensive Cancer Center Perspective

Conjunctival melanoma : Standard operating procedures in diagnosis, treatment and follow-up care

Rituximab Added to an Intensified Salvage Chemotherapy Program Followed by Autologous Stem Cell Transplantation Improve in Relapsed and Refractory Aggressive Non-Hodgkin-Lymphoma

Comparison of the Sequential High-Dose Chemotherapy Followed by Autologous Stem Cell Support with and without Rituximab in Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy: results of a randomized trial

Suchergebnisse filtern